Skip to main content
Trending storyWatching

Microbiotica raises €42M Series C first close

1 reports1 report sources2 days agoUpdate

Get up to speed on this story

AI Summary

British clinical-stage biopharma Microbiotica announced the first close of a €42 million (£36 million) Series C round led by British Business Bank. Tencent, IP Group, Cambridge Innovation Capital, Flerie Invest and Seventure Partners also participated, and Microbiotica said all existing Series B investors joined. The company said the proceeds will fund MB310's move into Phase 2 clinical development in ulcerative colitis, following positive results from the COMPOSER-1 Phase 1b study.

AI-generated from reports · 2 days agoUpdate

Latest updatesOct 16 19:12
Microbiotica raises €42M Series C for inflammatory bowel disease treatment

Report timeline

Follow the reports to understand different sides of the story.

Oct 16
  1. EU-StartupsTop Deals
    Microbiotica raises €42M Series C for inflammatory bowel disease treatment

    British clinical-stage biopharma company Microbiotica announced the first close of a €42 million Series C round led by British Business Bank.

Trend for this story

Not enough continuous observation data yet; trend chart is not drawn for now.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing